Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women

This study, published in Menopause in 2010 (PMID: 20632462), investigated the relationship between sex hormone levels and inflammatory markers in postmenopausal women, both undergoing hormone therapy and not. Findings indicate that while hormone therapy can reduce vascular inflammation, oral estradiol therapy raises C-reactive protein (CRP), a marker of generalized inflammation.